CHI Memorial, Chattanooga, TN, and The Chattanooga Heart Institute have a new treatment for people who have non-valvular atrial fibrillation (AFib). An estimated five million people in the U.S. are affected by AFib, an irregular heartbeat that brings a greater risk of stroke.
CHI Memorial now offers the implantation of a device that closes off the heart’s left atrial appendage (LAA). This may reduce the risk of stroke by keeping any blood clots that form in the LAA from entering the blood stream and potentially causing a stroke. Patients with the implanted device may be able to stop taking anticoagulants, which is helpful for patients who can’t tolerate blood-thinning medication long-term.
The device has already been implanted in more than 50,000 patients around the world. Implantation is a one-time procedure, and the device does not need replacement.